Your Cart ( 1 Item )

• Secukinumab Self-Administration by Prefilled Syringe Maintains Reduction of Plaque Psoriasis Severity Over 52 Weeks: Results of the FEATURE Trial
  October 2016 | Volume 15 | Issue 10 | Original Article | 1226 | Copyright © October 2016
  Alice B. Gottlieb MD PhD,^a Andrew Blauvelt MD MBA,^b Jörg C. Prinz MD,^c Philemon Papanastasiou PhD,^d Rashidkhan Pathan MS,^e Judit Nyirady MD MBA,^f Todd Fox PharmD ACPR,^d Charis Papavassilis MD PhD^d
  You will have 48 hours to download the full-text PDF

  Price

  24.95

  Term

  48 Hrs